(19)
(11) EP 0 833 835 A1

(12)

(43) Date of publication:
08.04.1998 Bulletin 1998/15

(21) Application number: 96921702.0

(22) Date of filing: 20.06.1996
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
C07K 1/ 113( . )
C07K 7/ 06( . )
C07K 14/ 47( . )
C12P 21/ 02( . )
C12R 1/ 19( . )
A23J 3/ 32( . )
C07K 5/ 083( . )
C07K 7/ 08( . )
C07K 14/ 575( . )
A61K 38/ 00( . )
(86) International application number:
PCT/US1996/010613
(87) International publication number:
WO 1997/000886 (09.01.1997 Gazette 1997/03)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
AL LT LV SI

(30) Priority: 22.06.1995 US 19950000451

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • HALE, John, Edward
    Fishers, IN 46038 (US)
  • MACKELLAR, Warren, Cameron
    Plainfield, IN 46168 (US)

(74) Representative: Denholm, Anna Marie, et al 
Eli Lilly and Company Limited, Lilly Research Center, Erl Wood Manor
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) OBESITY PROTEIN INTERMEDIATES AND THEIR PREPARATION AND USE